Payers are increasingly auditing and taking aggressive legal positions against out-of-network providers they allege are not properly collecting co-payments and deductibles from patients. But there are steps you can take to help minimize your lab’s risk. Find out what those are when you purchase the CD of the latest webinar from Pathology Webinars.
Purchase the CD of this webinar that originally aired on May 18, 2016 to hear David Gee and Caitlin Forsyth, both from Davis Wright Tremaine LLP, provide the latest information on the challenges of being an out-of-network laboratory. While the law is still far from settled, you’ll get advice on the steps you can take to reduce your risk of running afoul of the Anti-Kickback statute, state insurance laws, and common law causes of action like fraud and unjust enrichment.
David Gee is a partner in the firm of Davis Wright Tremaine LLP. He is a seasoned healthcare attorney with more than twenty-five years of experience representing clinical and pathology laboratories across the country. Mr. Gee routinely counsels clinical and pathology clients on regulatory compliance, business operations and transactions, corporate governance, HIPAA and Stark regulations, Medicare and Medicaid reimbursement, managed care, and quality assurance. With a dozen years of experience working as in-house legal counsel for three of the nation’s largest clinical lab companies, including as an executive officer, Mr. Gee brings both a legal and business perspective to his practice.
Mr. Gee received a BA in Economics from Brigham Young University and graduated magna cum laude from Brigham Young University’s J. Reuben Clark Law School. He has been named one of the “Best Lawyers in America” in healthcare law by Woodward/White, from 2012 to the present.
Caitlin Forsyth is an associate with Davis Wright Tremaine LLP. She focuses her practice on the healthcare industry, regularly providing guidance to healthcare providers on a wide spectrum of regulatory matters, including changes of ownership; federal and state licensure requirements; state health information privacy laws; Medicare and Medicaid coverage, reimbursement, and compliance; telemedicine; and other regulatory matters.
Ms. Forsyth also serves as regulatory counsel for a number of clinical, molecular, and toxicology laboratories. She provides advice on an array of issues, including regulatory laws (e.g., CLIA, HIPAA, Stark, Anti-Kickback, False Claims Act), billing and reimbursement, state law distinctions, government guidance (OIG Fraud Alerts and Advisory Opinions), documentation requests (particularly Medicare CERT audits), and phlebotomy/specimen collection.
Ms. Forsyth received her BA in biology from the University of San Diego and her JD from the University of Washington School of Law.